Nuedexta (dextromethorphan hydrobromide and quinidine sulfate) — Medica
Pseudobulbar affect associated with a chronic neurological condition (e.g., amyotrophic lateral sclerosis, multiple sclerosis, stroke, dementia, traumatic brain injury)
Initial criteria
- Patient has pseudobulbar affect associated with a chronic neurological condition
- Nuedexta is prescribed by or in consultation with a neurologist
Approval duration
1 year